Acaster Lloyd Consulting Poster presentation at the American Psychiatric Association (APA) Annual Meeting

Acaster Lloyd Consulting, in a team led by director Sarah Acaster, have had the pleasure of working with Sage Therapeutics during their achievement of the first FDA approved treatment for postpartum depression. A fantastic result for the women and their families in this critical population. As part of this work stream, in an effort to relate patient-reported and clinician-reported outcomes, our director, Sarah Acaster, was part of a study team to explore the relationship between the Hamilton Depression Rating Scale (HAM-D) and Edinburgh Post Natal Depression Scale (EPDS). If you’re going to APA next week you can view the related poster: ‘The association between the HAM-D and EPDS in postpartum depression’ in the poster session on Tuesday 21st May ref: P7-092.

Look out for news of further dissemination associated with this work.

2019 Annual Meeting